Clinical Relevance of Pharmacogenetics in Serotonin Syndrome
Serotonin syndrome is a predictable life-threatening condition that is caused by serotonergic stimulation of the central and peripheral nervous systems. A patient’s genetic profile can amplify exposure risk as many serotonergic drugs are metabolized by CYP450 enzymes, and these enzymes may be altere...
Main Authors: | Dehuti Pandya, My Tran, Monica Verduzco-Gutierrez |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2020/8860434 |
Similar Items
-
Relevance of G-quadruplex structures to pharmacogenetics
by: Martin A Kennedy, et al.
Published: (2014-07-01) -
MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
by: Rafael eDe La Torre, et al.
Published: (2012-11-01) -
Pharmacogenetics in Clinical Practice
by: Hana Bakhouche, et al.
Published: (2012-01-01) -
Clinical Applications of Pharmacogenetics
Published: (2012) -
Clinical applications of pharmacogenetics
by: Tate, S. K.
Published: (2007)